Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs

RATIONALE: Results from clinical trials in patients with severe eosinophilic asthma have demonstrated that mepolizumab is well tolerated and is associated with improved asthma control as evidenced by reductions in both exacerbations and maintenance oral corticosteroid use, and improvements in lung f...

Descripción completa

Detalles Bibliográficos
Autores principales: Llanos, Jean-Pierre, Ortega, Hector, Bogart, Michael, Packnett, Elizabeth R, Manjelievskaia, Janna, Bell, Christopher F, Hahn, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996212/
https://www.ncbi.nlm.nih.gov/pubmed/32099413
http://dx.doi.org/10.2147/JAA.S236609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996212/
https://www.ncbi.nlm.nih.gov/pubmed/32099413
http://dx.doi.org/10.2147/JAA.S236609

Ejemplares similares